That's 4 more trials than you will be doing in H2 FY23.
OA on track end 2023. Recruitment accelerating last 2-3 months, and we know it's well over 200 now....
One big statement Ross made today was "Execute" Partnerships 2023 vs past language of "Ongoing Discussions" First time I've heard that bold call.
GvHD will be conducted US, Oz, UK. *Reason for slight delays are vetting of hospitals more thoroughly for recruitment targets/capabilities. (lessons from MEND?)
Also confirmed today, IND was accepted first submission and within 30 days response. (vs likes of PAR back and forward)....stating our CMC dossier is solid! Ross also reiterated the flawed tech of GEN 1 companies....
Best to be 100% on these things vs rushing into poorly executed and designed trials and failing multiple endpoints one after the other. CHF, CLBP, Covid.
2023 looks positive.
Gee, I hope I haven't offended any poor soul this time
CYP Price at posting:
35.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
.
(20min delay)